The larynx is a site in the respiratory tract of animals that often shows a response to inhaled substances. In many cases, the most sensitive endpoint in repeated dose inhalation studies is squamous metaplasia (often of minimal severity) of the larynx. The U.S. Environmental Protection Agency has speculated that squamous metaplasia in the rodent larynx might be a pre-neoplastic lesion or a precursor to other serious effects and has proposed to use the effect of squamous metaplasia occurring in subchronic inhalation toxicology studies as a toxicologic endpoint for use in quantitative risk assessment [U.S. Environmental Protection Agency, 2006a. Reregistration Eligibility Decision for MGK-264, U.S. Environmental Protection Agency, 2006b, Reregistration Eligibility Decision for Piperonyl Butoxide, U.S. Environmental Protection Agency, 2006c. Reregistration Eligibility Decision for Pyrethrins]. To reach a conclusion as to its significance, we sought to establish the nature of this effect in the relevant context of rodent inhalation studies. A comprehensive review of the literature shows that laryngeal metaplasia can be produced by a wide range of chemically dissimilar substances, and even by "non-chemical" means such as irritation by aerosols and particles, and dehydration by alcohols or low humidity air. There is no published evidence that this effect is pre-neoplastic and it is clearly and repeatedly characterized as an adaptive response. Moreover, the well-differentiated character of laryngeal squamous metaplasia, the reversibility of incidence and severity of it during recovery periods, combined with no significant clinical observations and the lack of progression over time indicates that this response is adaptive and should not be considered to be indicative of significant human risk. We therefore conclude that squamous metaplasia of the rodent larynx is not a relevant toxicologic endpoint.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.taap.2007.08.027 | DOI Listing |
J Clin Neurosci
January 2025
Department of Neurosurgery, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
Background: Craniopharyngiomas are epithelial tumors derived from the remnants of the Rathke pouch, while Rathke cleft cysts (RCC) are benign cystic lesions originating from the Rathke pouch itself [1]. Rathke cleft cysts comprise 10-15% of the hypophyseal tumors, while craniopharyngiomas are relatively rare, comprising only 2-5% of intracranial tumors [2]. Both located in the sellar and parasellar regions and share clinical symptoms including headache, visual disturbances, and endocrine dysfunction [3].
View Article and Find Full Text PDFJ Cell Mol Med
January 2025
Department of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
The development of efficient platforms for the evaluation of anti-angiogenic agents is critical in advancing cancer therapeutics. In this study, we exploited an ultrabright semiconducting polymer dots (Pdots) integrating with a three-dimensional (3D) near-infrared-II (NIR-II) fluorescence imaging system designed to assess the efficacy of potent anti-angiogenic agents PX-478 and BPR0C261 in an oral squamous cell carcinoma (OSCC) tumour model, which depends on angiogenesis for dissemination. PX-478, a hypoxia-inducible factor-1α (HIF-1α) inhibitor, and BPR0C261, a microtubule-disrupting agent, were administrated into tumour-bearing mice established using murine MTCQ1 tongue cancer cells through intraperitoneal injection and oral gavage, respectively.
View Article and Find Full Text PDFJ Cutan Pathol
January 2025
Division of Dermatology, The University of Texas at Austin, Dell Medical School, Austin, Texas, USA.
Pemetrexed is a chemotherapeutic, antimetabolite agent that has been used in oncology to treat diseases such as metastatic non-small cell lung cancer and unresectable malignant pleural mesothelioma. Pemetrexed use may result in pseudocellulitis, which presents as poorly demarcated patches or plaques with erythema, edema, warmth, and tenderness. These lesions can present unilaterally or bilaterally on the lower extremities.
View Article and Find Full Text PDFSci Rep
December 2024
Department of Dermatology, Hebei Medical University Third Hospital, 139 Ziqiang Road, Shijiazhuang, 050000, Hebei, China.
To investigate CHD1L's impacts and molecular processes in hypoxic cutaneous squamous cell carcinoma. Monoclonal proliferation assays and CCK-8 were used to detect the proliferation capacity of A431 cells and Colon16 cells; wound healing experiments and Transwell assays were used to examine the migration and invasion capacity of A431 cells and Colon16 cells; angiogenesis experiments were conducted to assess the influence of A431 cells on angiogenesis; a nude mouse tumor xenograft experiment and HE staining were utilized to evaluate the impact of CHD1L on the progression of cutaneous squamous cell carcinoma; western blot analysis was performed to detect the expression of p-PI3K, p-AKT, and PD-L1 in A431 cells, as well as CD9, TSG101, PD-L1 in exosomes, and CD206, Arginase-1, iNOS, IL-1β, p-AKT, p-mTOR, VEGF, COX-2, MMP2, MMP9, p-ERK1/2 in tumor-associated macrophages. Under hypoxic conditions, CHD1L promoted the proliferation, migration, invasion, and angiogenesis of cutaneous squamous cell carcinoma.
View Article and Find Full Text PDFNan Fang Yi Ke Da Xue Xue Bao
December 2024
Department of Stomatology, Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.
Objectives: To investigate the mechanism of PHPS1 for promoting apoptosis of oral squamous cell carcinoma cells and the role of AMPK in regulating tumor angiogenesis under hypoxic conditions.
Methods: Human oral squamous cell carcinoma Ca9-22 cells cultured in hypoxic conditions (1% O) were inoculated subcutaneously in 16 nude mice, which were divided into control group and PHPS1 group (8) for treatment with 10% DMSO and 10% PHPS1 respectively. Tumor growth in the mice was monitored till 14 days after the treatment, and the xenografts were examined pathologically using HE staining.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!